Ad
related to: mild cerebral atrophy life expectancy- Efficacy & Study Info
Find Efficacy Data & Learn More
About An RMS Treatment Option
- RMS Clinical Trials
Access Trial Information & View
Clinical Endpoint Data.
- Find HCP Support
View HCP Support & Resource
Material On Official Rx Website.
- Dosing & Initiation Info
Learn About First Dosing For
An RMS Treatment Option.
- View The Safety Profile
Read About The Safety Profile For
An RMS Treatment Option.
- Prescribing Information
See Full PI For A Relapsing
Multiple Sclerosis Rx Option.
- Efficacy & Study Info
Search results
Results From The WOW.Com Content Network
Cerebral atrophy is a common feature of many of the diseases that affect the brain. [1] Atrophy of any tissue means a decrement in the size of the cell, ...
Cerebellar degeneration is a condition in which cerebellar cells, otherwise known as neurons, become damaged and progressively weaken in the cerebellum. [1] There are two types of cerebellar degeneration; paraneoplastic cerebellar degeneration, and alcoholic or nutritional cerebellar degeneration. [2]
Ischemic changes in the brain are irreversible, but the person with vascular dementia can demonstrate periods of stability or even mild improvement. [18] Since stroke is an essential part of vascular dementia, [ 13 ] the goal is to prevent new strokes.
The most severe brain atrophy appears to be associated with behavioral variant FTD, and corticobasal degeneration. [42] With regard to the genetic defects that have been found, repeat expansion in the C9orf72 gene is considered a major contribution to FTLD, although defects in the GRN and MAPT genes are also associated with it. [43]
Cerebellar ataxia is a form of ataxia originating in the cerebellum. [1] Non-progressive congenital ataxia (NPCA) is a classical presentation of cerebral ataxias.. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. [2]
Progressive cerebello-cerebral atrophy (PCCA) PCH2E 615851: VPS53: 17p13.3 Profound mental retardation, progressive microcephaly, spasticity, and early-onset epilepsy [7] PCH2F 617026: TSEN15: 1q25.3 Variable neurologic signs and symptoms, including cognitive and motor delay, poor or absent speech, seizures, and spasticity PCH3 608027: PCLO ...
While the disease is fatal, the age of onset is a key factor, as infants have a typical life expectancy of 2–8 years, while adults typically live more than a decade after onset. Treatment options are limited, although hematopoietic stem cell transplantations using bone marrow or cord blood seem to help in certain leukodystrophy types, while ...
Wichman et al. in 1985 reported three sibling pairs with congenital cerebellar hypoplasia. "All six children presented in the first years of life with delays in motor and language development. All patients showed cerebellar and/or vermal dysfunction and, on formal psychometric testing, cognitive abilities ranged from normal to moderately retarded.